Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma.
Emma Andersson-EvelönnLinda VidmanDavid KällbergMattias LandforsXijia LiuBörje LjungbergMagnus HultdinPatrik RydénSofie DegermanPublished in: Journal of translational medicine (2020)
The triple classifier panel that combines clinicopathological variables with genome-wide methylation data has the potential to improve specificity in prognosis prediction for patients with non-metastatic ccRCC.